Clinical Trials
3
Active:1
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 1
1 (33.3%)Phase 2
1 (33.3%)Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2015-09-07
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Calibra Medical, Inc.
- Target Recruit Count
- 278
- Registration Number
- NCT02542631
- Locations
- 🇺🇸
Central Phoenix Medical Clinic, Phoenix, Arizona, United States
🇺🇸Advanced Metabolic Care & Research Institute, Inc. (AMCR), Escondido, California, United States
🇺🇸Marin Endocrine Care and Research, Greenbrae, California, United States
Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections
Phase 2
Completed
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Calibra Medical, Inc.
- Target Recruit Count
- 38
- Registration Number
- NCT01073566
- Locations
- 🇺🇸
California Pacific Medical Center, San Francisco, California, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸Henry Ford Health System, Detroit, Michigan, United States
News
No news found